Prosecution Insights
Last updated: October 02, 2026

Insitro Inc.

Technology areas: Biotechnology & Pharmaceuticals • Communications

5 pending office actions • 2 art units • 4 examiners • 0 of 5 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days

Analysis

Insitro Inc. is managing 5 pending office actions within the Communications technology area. These matters are distributed among 4 distinct examiners across 2 distinct art units. This indicates that at least one examiner is handling multiple applications for the company, while the overall workload is concentrated within just two specialized groups. The focus on 2 distinct art units suggests a relatively narrow technical scope within the communications field.

GEBRESLASSIE, WINTA is the busiest examiner for the portfolio, currently overseeing 2 busiest examiner pending actions. With 5 pending office actions in total, this examiner handles a significant portion of the company's active workload. The concentration of five actions within only 2 distinct art units suggests a focused review process within the communications department. Practitioners should note that the company's prosecution success is heavily influenced by the 4 distinct examiners assigned to these matters.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

5
Total Pending OAs
3
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
1
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (40%)
2
Medium (40%)
1
Easy (20%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only2 (40%)
§112 only1 (20%)
Multi-statute (no §101)2 (40%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
20% of docket
0
Information Tech
0% of docket
3
Communications
60% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
20% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

50 h
Manual time on pending OAs
10 h
Time saved (low, 20%)
18 h
Time saved (mid, 35%)
0.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
GEBRESLASSIE, WINTA 2 77.1% +23.6%
RIVERA-MARTINEZ, GUILLERMO M 1 78.0% +3.3%
ISLAM, PROMOTTO TAJRIAN 1 77.4% +13.8%
VANN-OJUEKAIYE, KENDRA RAYCHELL 1 0.0% +0.0%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18592877 AUTONOMOUS MAINTENANCE AND DIFFERENTIATION OF INDUCED PLURIPOTENCY CELLS ISLAM, PROMOTTO TAJRIAN —
18113481 POOLED OPTICAL SCREENING AND TRANSCRIPTIONAL MEASUREMENTS OF CELLS COMPRISING BARCODED GENETIC PERTURBATIONS VANN-OJUEKAIYE, KENDRA RAYCHELL —

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
19177402 MACHINE-LEARNING-ENABLED PREDICTIVE BIOMARKER DISCOVERY AND PATIENT STRATIFICATION USING STANDARD-OF-CARE DATA GEBRESLASSIE, WINTA 71d
19205753 MACHINE-LEARNING-ENABLED PREDICTIVE BIOMARKER DISCOVERY AND PATIENT STRATIFICATION USING STANDARD-OF-CARE DATA GEBRESLASSIE, WINTA —
18592877 AUTONOMOUS MAINTENANCE AND DIFFERENTIATION OF INDUCED PLURIPOTENCY CELLS ISLAM, PROMOTTO TAJRIAN —

Top Art Units

Art UnitApps
2677 3
1682 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19205753 MACHINE-LEARNING-ENABLED PREDICTIVE BIOMARKER DISCOVERY AND PATIENT STRATIFICATION USING STANDARD-OF-CARE DATA GEBRESLASSIE, WINTA 2677 §103 Non-Final OA — Pending May 12, 2025
19177402 MACHINE-LEARNING-ENABLED PREDICTIVE BIOMARKER DISCOVERY AND PATIENT STRATIFICATION USING STANDARD-OF-CARE DATA GEBRESLASSIE, WINTA 2677 §103 Non-Final OA 71d Pending Apr 11, 2025
18666672 CELLULAR TIME-SERIES IMAGING, MODELING, AND ANALYSIS SYSTEM RIVERA-MARTINEZ, GUILLERMO M 2677 §112 Final Rejection 29d Pending May 16, 2024
18592877 AUTONOMOUS MAINTENANCE AND DIFFERENTIATION OF INDUCED PLURIPOTENCY CELLS ISLAM, PROMOTTO TAJRIAN — §102§112 Non-Final OA — Pending Mar 01, 2024
18113481 POOLED OPTICAL SCREENING AND TRANSCRIPTIONAL MEASUREMENTS OF CELLS COMPRISING BARCODED GENETIC PERTURBATIONS VANN-OJUEKAIYE, KENDRA RAYCHELL 1682 §103§112 Final Rejection — Pending Feb 23, 2023

Managing Insitro Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month